Target intelligence / Profile preview

Methyl group donor

Molecular classification
Other (functional chemical class, not a specific molecule), Metabolic cofactor (general category)
01

Overview

A **methyl group donor** is not a single molecular entity but rather refers to any compound capable of donating a methyl group (\(-CH_3\)) in biochemical reactions. The process by which these groups are transferred—*methylation*—is essential for numerous cellular functions including DNA and RNA synthesis, gene regulation through epigenetic modification, protein synthesis, neurotransmitter production, and fatty acid metabolism[1][2][3]. Common biological methyl donors include **methionine**, **S-Adenosylmethionine** (*SAMe*), **choline**, **betaine** (*trimethylglycine*), *dimethylglycine*, *sarcosine*, *folate derivatives*, and *methylcobalamin*[2]. These molecules participate in enzymatic reactions that transfer their methyl groups to acceptor molecules. The term “methyl group donor” does not refer to a unique therapeutic target such as an enzyme or receptor but rather describes the functional role played by several different metabolites within one-carbon metabolism. Therefore it is considered an incorrect entry if used as the name for a drug target or receptor[4]. In summary: “Methyl group donor” designates any substance that can donate a -CH₃ unit during metabolic processes. It is not itself an individual molecular target but encompasses several important nutrients and cofactors critical for health[1][2].

Other names
Methyl donorMethylating agentCH₃ group donor
02

Biological functions

Methylation of biomoleculesEpigenetic regulation (via DNA and histone methylation)Synthesis of nucleic acids and proteinsRegulation of gene expression
03

Disease associations

Cancer (aberrant methylation patterns)Neurodegenerative disease (impaired methylation cycles)Cardiovascular disease (homocysteine metabolism)Other metabolic disorders

Beyond the preview

Go deeper on Methyl group donor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyl group donor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call